FDA - Diplomatico

Concerns Rise Among Biotech Leaders Over FDA Leadership Changes and Their Effects on Rare Disease Drugs

The recent departure of significant FDA officials has sparked worries among biotech executives about the future of rare disease drug development, emphasizing the need for regulatory stability.

Editorial Staff 6 days ago

Life Medicine

Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns

Tracy Beth Høeg's resignation from the FDA's drug center follows the recent departure of Commissioner Marty Makary, highlighting a troubling leadership gap within the agency.

Editorial Staff 11 days ago

World North America

Trump Suggests Reevaluation of Kratom Derivative 7-OH Amid FDA Concerns

In a notable shift, President Trump has indicated that certain forms of the kratom derivative 7-OH may warrant approval, despite prior warnings from the FDA about its risks.

Editorial Staff 15 days ago

#FDA

Concerns Rise Among Biotech Leaders Over FDA Leadership Changes and Their Effects on Rare Disease Drugs

Concerns Grow as FDA Drug Center Head Tracy Beth Høeg Resigns

Trump Suggests Reevaluation of Kratom Derivative 7-OH Amid FDA Concerns